[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342223-105":59,"doc-detail-342223-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","advancing-inclusive-research-calculator-for-oncology-disease-areas-a-resource-to-support-the-development-of-enrollment-targets-in-diversity-action-plans-for-industry-sponsors","Advancing inclusive research calculator for oncology disease areas - A resource to support the development of enrollment targets in diversity action plans for industry sponsors","","The Food and Drug Omnibus Report Act (2022) requires industry sponsors to include diversity action plans in clinical study protocols, making dependable measurement and benchmarking essential for consistent representation of historically underrepresented patient groups. The study presents an Advancing Inclusive Research (AIR) Calculator, summary tables, and a data query bank to support enrollment target setting. The tool uses the US Cancer Statistics database (2015–2019) covering 26 cancer sites, stratified by diagnosis stage and demographic factors, and provides incidence metrics and robustness testing by year of diagnosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advancing-inclusive-research-calculator-for-oncology-disease-areas-a-resource-to-support-the-development-of-enrollment-targets-in-diversity-action-plans-for-industry-sponsors/342223/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advancing-inclusive-research-calculator-for-oncology-disease-areas-a-resource-to-support-the-development-of-enrollment-targets-in-diversity-action-plans-for-industry-sponsors/342223.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the AIR Calculator address in oncology diversity planning?","Question",{"text":112,"@type":113},"It supports development of enrollment targets for diversity action plans by providing representative distributions for clinical study populations based on disease patterns in the US.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data source does the AIR Calculator use?",{"text":117,"@type":113},"It uses the US Cancer Statistics database covering the full US population, using diagnoses from 2015–2019.",{"name":119,"@type":110,"acceptedAnswer":120},"What analyses and outputs does the resource provide?",{"text":121,"@type":113},"It provides descriptive statistics such as frequency counts, age-adjusted incidence rates, incidence rate ratios, 95% confidence intervals, and robustness test results available via the data query bank by year of diagnosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342223,1790559047,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","PLOS ONE  \nOPEN ACCESS  \nCitation: Press DJ, James SL, Jolain B, Richie N (2024) Advancing inclusive research calculator for oncology disease areas: A resource to support the development of enrollment targets in diversity action plans for industry sponsors. PLoS ONE 19(12): e0315283 . [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0315283  \nEditor: Caroline Watts, The University of Sydney, AUSTRALIA  \nReceived: June 18, 2024  \nAccepted: November 24, 2024  \nPublished: December 19, 2024  \nCopyright: © 2024 Press et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: All relevant data are within the manuscript and its Supporting information files.  \nFunding: This study was sponsored by Genentech, A Member of the Roche Group, which provided support in the form of salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of  \nRESEARCH ARTICLE  \nAdvancing inclusive research calculator for oncology disease areas: A resource to support the development of enrollment targets in diversity action plans for industry sponsors  \nDavid J. Press1,2 *, Spencer L. James1, Bruno Jolain3, Nicole Richie1  \n1 A Member of the Roche Group, Genentech, South San Francisco, California, United States of America, 2 Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, United States of America, 3 F. Hoffman-La Roche Ltd. , Basel, Switzerland  \n* [david.johann.press@gmail.com](david.johann.press@gmail.com)  \nAbstract  \nBackground  \nThe Food and Drug Omnibus Report Act, signed into law in 2022, requires industry sponsors to include diversity action plans in clinical study protocols. Defining reliable methodology for measures and benchmarks is critical to ensuring adequate and consistent representation of historically underrepresented patient populations in clinical trials.  \nMethods  \nWe provide an Advancing Inclusive Research (AIR) Calculator, summary tables, and data query bank to support target setting for the development of diversity action plans and to take steps toward defining enrollment standards. The AIR Calculator uses data from the US Cancer Statistics database, which covers 100% of the US population. The database provides descriptive statistics for people diagnosed with 26 different cancers from 2015–2019 by cancer site, age at diagnosis, sex, and race and ethnicity, all stratified by stage at diagnosis (early, de novo metastatic, and combined) . Descriptive characteristics include frequency counts, age-adjusted incidence rates, incidence rate ratios, and 95% CIs. Robustness test results are available in the data query bank by year of diagnosis.  \nResults  \nThis resource offers insights into distributions of cancer in the US. The AIR Calculator allows users to calculate representative clinical study distributions based on the sponsordesignated study size.  \nDiscussion  \nThe AIR Calculator serves as a valuable resource for planning of clinical studies, but additional data analyses are necessary for a comprehensive understanding at the study level. Comprehensive data collection and alignment across industry are essential to ensure  \nthese authors are articulated in the author contributions section.  \nCompeting interests: D.J. Press, S. L. James and N. Richie were employees and shareholders of Genentech, a member of the Roche Group, at the time of this analysis. B. Jolain was an employee and shareholder of F. Hoffmann-La Roche Ltd., atthe time of this analysis. This study was sponsored by F. Hoffmann-La Roche Ltd. This does not alter our adherence to PLOS ONE policies on sharing data and materials.  \nconsistent, accurate, and transparent benchmarks in","cbCaif7kDR7czYd8","https://ap.wps.com/l/cbCaif7kDR7czYd8","pdf",442392,"English","# Abstract\n## Background\n## Methods\n## Results\n## Discussion\n# Introduction\n# Materials and methods\n## Data","[{\"question\":\"What problem does the AIR Calculator address in oncology diversity planning?\",\"answer\":\"It supports development of enrollment targets for diversity action plans by providing representative distributions for clinical study populations based on disease patterns in the US.\"},{\"question\":\"Which data source does the AIR Calculator use?\",\"answer\":\"It uses the US Cancer Statistics database covering the full US population, using diagnoses from 2015–2019.\"},{\"question\":\"What analyses and outputs does the resource provide?\",\"answer\":\"It provides descriptive statistics such as frequency counts, age-adjusted incidence rates, incidence rate ratios, 95% confidence intervals, and robustness test results available via the data query bank by year of diagnosis.\"}]","Advancing inclusive research calculator for oncology disease areas - A resource to support the development of enrollment targets in diversity action plans for industry sponsors | PDF",1790045838,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65cde87f6a5c22bc8d62bd30bae23e47.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd91813d6e375c1093f49b49485f15a4.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d2651ad2fd7e59dbc4e5cff1e103a40.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8ba8d77bc806089ba426fbe6de1f5cf.webp",980,1268]